apple-podcastbusiness_services_kachelcheckchevron-downchevron-leftchevron-rightchevron-upcloseemailenvelopeexclamation-markicon-arrow-bottom-righticon-anfahrticon-downloadicon-expertensucheicon-highlighticon-linkicon-standortinfoicon-vcardicon-veranstaltungeninternationalmagnifierphonepin-iconquotespotifyteaser-icon-artikelteaser-icon-podcastteaser-icon-videotype-icon-veranstaltungdefault-map-cluster-markerdefault-map-markerfacebookinstagramlinkedintwitterxingyoutubeplay-buttoncogs-solideye-slasheyeimageserrorinfostatuswarningmobile-alt

News & Events

News

Here you will find the most recent news/events from our law firm as well as analyses and articles on the latest legal issues.

Year
Title
Healthcare and Life Sciences
Cannabis legalisation: What plans does Germany’s incoming government have?
Mandate
Gleiss Lutz obtains landmark Federal Administrative Court ruling for statutory health insurers on financing of mandatory staffing requirements
Healthcare and Life Sciences
Healthcare: Key changes and unresolved issues in the coalition agreement
Firm News
Chambers Germany Awards 2025: Gleiss Lutz named “Competition Law Firm of the Year” and “Healthcare & Life Sciences Law Firm of the Year”
Healthcare and Life Sciences Public Procurement
European Commission publishes Critical Medicines Act proposal
Healthcare and Life Sciences
Federal Court of Justice rules on pharmacy marketplaces: Green light for digital sales models (BGH I ZR 46/24)
Mandate
Gleiss Lutz advises Körber on acquisition of Bähren Pharma-Packaging
Firm News
Hot
Topic
Gleiss Lutz appoints new partners and counsel
Mandate
Gleiss Lutz advises Klett Group on acquisition of majority interest in Careloop
Data Protection Digital Economy Digital Future
Strategies for (healthcare) companies to utilize cloud computing in a legally compliant manner
Healthcare and Life Sciences
Hot
Topic
Telemedicine update: Legal framework and development prospects amid push for healthcare digitalisation
Mandate
Gleiss Lutz advises Robus Capital and other shareholders of TTP Group on sale to Exyte
Mandate
Gleiss Lutz advises SYNLAB AG in connection with its delisting and on Cinven’s delisting acquisition offer
Firm News
‘Best Lawyers’ in Germany – 14 Lawyer of the Year Awards and 372 recommendations
Healthcare and Life Sciences
Cannabis legalisation in Germany: What will change in the medical sector?

Mandates & Firm News

Click here for Information on our mandates and firm news

More

Know-How

We comment on current legal developments and issues for you
More

Events

Here you can get an overview of all Gleiss Lutz events at a glance More
Keep in Touch

Keep in Touch
Gleiss Lutz keeps you informed

We would be pleased to add you to our mailing list so that we can keep you informed about current legal developments and events.

Subscribe now